Feasibility of Implementing Acupuncture Into Federally Qualified Health Center Among Breast Cancer Survivors

Sponsor
University of Illinois at Chicago (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05615753
Collaborator
(none)
62
2
28.9

Study Details

Study Description

Brief Summary

The purpose of this study is to test the feasibility of implementing acupuncture intervention in federally qualified health centers oncology clinics for breast cancer survivors.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Acupuncture
Phase 1

Detailed Description

This study has the following specific aims:

Aim 1: Test the feasibility and acceptability of implementing a 5-week acupuncture intervention within federally qualified health center oncology clinic to manage multiple symptoms (pain, hot flashes, fatigue, sleep disturbance, depression, anxiety) among breast cancer survivors receiving endocrine therapy.

Aim 2: Use a mixed methods approach to identify barriers and facilitators associated with implementing acupuncture in federally qualified health center oncology clinic.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
62 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Basic Science
Official Title:
Feasibility of Implementing Acupuncture Into a Federally Qualified Health Center to Alleviate Multiple Symptoms Among Breast Cancer Survivors
Anticipated Study Start Date :
Jan 1, 2023
Anticipated Primary Completion Date :
May 31, 2025
Anticipated Study Completion Date :
May 31, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Acupuncture group

Participants will receive 2 acupuncture treatments each week for 5 weeks, for a total of 10 treatments. Each acupuncture treatment will take 30 minutes.

Behavioral: Acupuncture
All participants will receive a semi-standardized acupuncture protocol with additional points for patient's particular pain location,

No Intervention: Usual care group

Participants will continue to receive their usual care.

Outcome Measures

Primary Outcome Measures

  1. Acceptability for Treating Multiple Symptoms with Acupuncture [At week 6 after finishing the 10th acupuncture treatment]

    Protocol Acceptability Scale is a 9-item instrument with scores ranging from 0 to 18 used to measure acceptability of the study processes and protocols. Items are measured on a 0 to 2 scale, where 0 means "did not like the study/did not like acupuncture/did not enjoy participating", and 2 means "liked the study/liked acupuncture/enjoyed participating". The protocol was deemed to have high acceptability if 80% of participants scored ≥ 80% of possible points on the acceptability scale. The investigators calculated the mean score for each of the 9 questions, divided the total score for the 9 questions by the maximum possible points for the measure, and converted the total mean scores to percentage of participants who liked the study/liked acupuncture/enjoyed participating.

  2. The numbers of study participants being recruited and retained (Feasibility) [: from the activation of the study to the completion of the recruitment, week 12]

    The numbers of study participants being recruited and retained during the study period will be documented as planned

  3. Identify barriers and facilitators associated with implementing acupuncture in federally qualified health center oncology clinics. [Through study completion, an average of 1 year]

    Specific questions will be asked during a face-to-face interview to identify factors favoring or barriers to implementing acupuncture into federally qualified health center oncology clinics among breast cancer survivors and providers.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • women with histologically confirmed stage 0, I, II, or III breast cancer

  • 18 years of old

  • who have completed their primary cancer treatment (e.g., surgery, radiotherapy, chemotherapy) in the past 1 month and currently taking endocrine therapy

  • are able to read and speak English

  • with self-reported pain, fatigue, sleep disturbance, depression, hot flashes and/or anxiety in the last month and their average severity rating ≥ 3 (0-10 numeric rating scale) for at least 3 of the 6 symptoms, and experience at least 2 physical symptoms (pain, fatigue, sleep disturbance).

Exclusion Criteria:
  • Metastatic breast cancer (stage IV)

  • have a bleeding disorder (e.g. hemophilia, Von Willebrand's disease, thrombocytopenia)

  • failure to comply with weekly visits to the acupuncture clinic during the interventional phase of the study

  • Psychiatric or medical disorders which would affect study assessments, such as, dementia, Alzheimer's disease, a history of any neurological condition, traumatic brain injury, stroke, and the use of psychotropic medication

  • Breastfeeding, pregnant or are planning get pregnant during the study period

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • University of Illinois at Chicago

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Hongjin Li, Assistant Professor, University of Illinois at Chicago
ClinicalTrials.gov Identifier:
NCT05615753
Other Study ID Numbers:
  • 2022-0353
First Posted:
Nov 14, 2022
Last Update Posted:
Nov 14, 2022
Last Verified:
Nov 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 14, 2022